143 related articles for article (PubMed ID: 25617801)
1. The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.
Che YL; Luo SJ; Li G; Cheng M; Gao YM; Li XM; Dai JM; He H; Wang J; Peng HJ; Zhang Y; Li WY; Wang H; Liu B; Linghu H
Cancer Lett; 2015 Apr; 359(2):241-9. PubMed ID: 25617801
[TBL] [Abstract][Full Text] [Related]
2. Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.
Samardzija C; Luwor RB; Quinn MA; Kannourakis G; Findlay JK; Ahmed N
BMC Cancer; 2016 Jul; 16():432. PubMed ID: 27390927
[TBL] [Abstract][Full Text] [Related]
3. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms.
Priego N; Arechederra M; Sequera C; Bragado P; Vázquez-Carballo A; Gutiérrez-Uzquiza Á; Martín-Granado V; Ventura JJ; Kazanietz MG; Guerrero C; Porras A
Oncotarget; 2016 Jul; 7(29):45060-45078. PubMed ID: 27286263
[TBL] [Abstract][Full Text] [Related]
4. Rap1 mutants with increased affinity for the guanine-nucleotide exchange factor C3G.
Shi S; Noda M; Kitayama H
Oncogene; 2004 Nov; 23(54):8711-9. PubMed ID: 15480424
[TBL] [Abstract][Full Text] [Related]
5. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
6. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis.
Ohba Y; Ikuta K; Ogura A; Matsuda J; Mochizuki N; Nagashima K; Kurokawa K; Mayer BJ; Maki K; Miyazaki J; Matsuda M
EMBO J; 2001 Jul; 20(13):3333-41. PubMed ID: 11432821
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
[TBL] [Abstract][Full Text] [Related]
9. C3G dynamically associates with nuclear speckles and regulates mRNA splicing.
Shakyawar DK; Muralikrishna B; Radha V
Mol Biol Cell; 2018 May; 29(9):1111-1124. PubMed ID: 29496966
[TBL] [Abstract][Full Text] [Related]
10. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de e Nictolis M; Garbisa S; Masiero L; Romanini C; Graziella B
Anticancer Res; 1995; 15(6B):2799-804. PubMed ID: 8669868
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells.
Schönherr C; Yang HL; Vigny M; Palmer RH; Hallberg B
Oncogene; 2010 May; 29(19):2817-30. PubMed ID: 20190816
[TBL] [Abstract][Full Text] [Related]
13. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
15. The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.
Guvakova MA; Lee WS; Furstenau DK; Prabakaran I; Li DC; Hung R; Kushnir N
Biochem J; 2014 Oct; 463(2):257-70. PubMed ID: 25028810
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.
Cho YJ; Hemmeryckx B; Groffen J; Heisterkamp N
Biochem Biophys Res Commun; 2005 Aug; 333(4):1276-83. PubMed ID: 15982636
[TBL] [Abstract][Full Text] [Related]
17. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
18. Signalling to actin: role of C3G, a multitasking guanine-nucleotide-exchange factor.
Radha V; Mitra A; Dayma K; Sasikumar K
Biosci Rep; 2011 Aug; 31(4):231-44. PubMed ID: 21366540
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
20. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
